VGNX: Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX: Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: Mike McFarland	3/17/2001 10:36:26 AM
	of 2

It is possible to infer haplotypes computationally from genotype data, and VARIAGENICS has exclusive relationships with leaders working in this field. However, given that the accuracy of these methods has not been established, especially for complex data, VARIAGENICS has developed a novel, proprietary laboratory technique for measuring haplotypes unambiguously. variagenics.com NuCleave™ Haplotype Genotype _________________________________________________________ I cannot resist this sort of thing, even though I have rather significant losses from owning Axys and Genset (and I still have positions in those two stinkers) well, I bought a little of this one, and a little bit of Orchid down here below $5.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext